Study Title and Description
Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.
Key Questions Addressed
|3||Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?|
Primary Publication Information
|Title||Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.|
|Author||Chalas E., Costantino JP., Wickerham DL., Wolmark N., Lewis GC., Bergman C., Runowicz CD.|
|Country||Department of Obstetrics, Gynecology and Reproductive Medicine, Stony Brook University, State University of New York, Stony Brook, NY, USA.email@example.com|
Pubmed ID: 15846210
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-4
Results & Comparisons
No Results found.